target,target_id,target_uniprot,target_species,ligand,ligand_id,ligand_species,ligand_pubchem_cid,smiles,inchi,inchikey,type,action,action_comment,endogenous,primary_target,concentration_range,affinity_parameter,affinity_high,affinity_median,affinity_low,original_affinity_units,original_affinity_low_nm,original_affinity_median_nm,original_affinity_high_nm,original_affinity_relation,assay_description,receptor_site,ligand_context,pubmed_id K2P10.1,521,P57789,Human,docosahexaenoic acid,1051,,445580,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O,"InChI=1S/C22H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22(23)24/h3-4,6-7,9-10,12-13,15-16,18-19H,2,5,8,11,14,17,20-21H2,1H3,(H,23,24)/b4-3-,7-6-,10-9-,13-12-,16-15-,19-18-",MBMBGCFOFBJSGT-KUBAVDMBSA-N,Activator,None,,,,,,,,,,,,,=,,,,10880510, K2P10.1,521,P57789,Human,linoleic acid,1052,,5280450,CCCCC/C=C\C/C=C\CCCCCCCC(=O)O,"InChI=1S/C18H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10H,2-5,8,11-17H2,1H3,(H,19,20)/b7-6-,10-9-",OYHQOLUKZRVURQ-HZJYTTRNSA-N,Activator,None,,,,,,,,,,,,,=,,,,10880510, K2P10.1,521,Q9JIS4,Rat,quinidine,2342,,441074,C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@H](c1ccnc2c1cc(OC)cc2)O,"InChI=1S/C20H24N2O2/c1-3-13-12-22-9-7-14(13)10-19(22)20(23)16-6-8-21-18-5-4-15(24-2)11-17(16)18/h3-6,8,11,13-14,19-20,23H,1,7,9-10,12H2,2H3/t13-,14-,19+,20-/m0/s1",LOUPRKONTZGTKE-LHHVKLHASA-N,Channel blocker,None,,,,,,,,,,,,,=,,,,12122143, K2P10.1,521,P57789,Human,arachidonic acid,2391,,444899,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O,"InChI=1S/C20H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-,16-15-",YZXBAPSDXZZRGB-DOFZRALJSA-N,Activator,None,studied at 1-10 µM,yes,,,,,,,,,,,=,,,,10880510, K2P10.1,521,P57789,Human,halothane,2401,,3562,ClC(C(F)(F)F)Br,"InChI=1S/C2HBrClF3/c3-1(4)2(5,6)7/h1H",BCQZXOMGPXTTIC-UHFFFAOYSA-N,Activator,None,studied at 1-5 mM,,yes,,,,,,,,,,=,,,,10880510, K2P10.1,521,P57789,Human,lysophosphatidylcholine,2508,,5311264,O[C@@H](COP(=O)(OCC[N+](C)(C)C)[O-])COC(=O)C,"InChI=1S/C10H22NO7P/c1-9(12)16-7-10(13)8-18-19(14,15)17-6-5-11(2,3)4/h10,13H,5-8H2,1-4H3/t10-/m1/s1",RYCNUMLMNKHWPZ-SNVBAGLBSA-N,Activator,None,,,,,,,,,,,,,=,,,,10880510, K2P10.1,521,P57789,Human,BL-1249,10336,,16078951,C1CCc2c(C1)c(ccc2)Nc1ccccc1c1n[nH]nn1,"InChI=1S/C17H17N5/c1-2-8-13-12(6-1)7-5-11-15(13)18-16-10-4-3-9-14(16)17-19-21-22-20-17/h3-5,7,9-11,18H,1-2,6,8H2,(H,19,20,21,22)",YYNRZIFBTOUICE-UHFFFAOYSA-N,Activator,None,,,,,pEC50,,5.1,,EC50,,8000.0,,=,,,,30089357, K2P10.1,521,P57789,Human,GI‐530159,10337,,94652,FC(C(C(F)(F)F)(c1ccc(cc1)Oc1ccc(cc1)N)c1ccc(cc1)Oc1ccc(cc1)N)(F)F,"InChI=1S/C27H20F6N2O2/c28-26(29,30)25(27(31,32)33,17-1-9-21(10-2-17)36-23-13-5-19(34)6-14-23)18-3-11-22(12-4-18)37-24-15-7-20(35)8-16-24/h1-16H,34-35H2",HHLMWQDRYZAENA-UHFFFAOYSA-N,Activator,None,,,,,,,,,,,,,=,Whole‐cell recording from tsA‐201 cells shows a 42% enhancement in hTREK2 channel current upon activation by 1 μM GI‐530139.,,,29150838,